Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Placebo for Muscle Symptoms (StatinWISE)
NCT02781064Phase 4Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypercholesterolemia and cardiovascular disease (CVD) comparing Atorvastatin 20mg with Placebo (2 arms). Primary endpoint: Visual Analogue Scale (VAS) Muscle Symptom Score at 48 weeks. Started Sep 2016; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiacardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02781064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02781064.